^

About ASTRO

Jeff M. Michalski

Jeff M. Michalski

Chair

Siteman Cancer Center, Washington University, St. Louis

EDUCATION

  • MBA, Washington University John Olin School of Business, St. Louis, 2001
  • MD, Medical College of Wisconsin-Milwaukee, 1986
  • BS, University of Wisconsin-Madison, Biochemistry, Madison, Wisconsin, 1982

POSTGRADUATE EDUCATION

  • Harvard School of Public Health, Boston, Leadership Development, Physicians in Academic Health Centers, Boston, 2004
  • Fellow, Mallinckrodt Institute of Radiology, Washington University School of Medicine, Radiation Oncology Center, Clinical Instructor/Fellow, St. Louis, 1990 - 1991
  • Resident, Mallinckrodt Institute of Radiology, Washington University School of Medicine, Radiation Oncology, St. Louis, 1988 - 1990
  • Resident, Columbia-Presbyterian Medical Center, New York, 1987 - 1988
  • Internship, Internal Medicine, Columbia-Presbyterian Medical Center, New York, 1986 - 1987

ACADEMIC APPOINTMENTS

  • The Carlos A. Perez Distinguished Professor of Radiation Oncology, Washington University School of Medicine, St. Louis, 2010 - present
  • Vice-chair and Director of Clinical Programs, Department of Radiation Oncology, Washington University School of Medicine, St. Louis, 2009
  • Tenured Professor of Radiation Oncology, Washington University School of Medicine, St. Louis, 2006
  • Tenured Associate Professor of Radiation Oncology, Washington University School of Medicine, St. Louis, 2002 - 2006
  • Assistant Professor of Radiology, Radiation Oncology, Washington University School of Medicine, St. Louis, 1995 - 2002
  • Instructor of Radiology, Radiation Oncology, Washington University School of Medicine, St. Louis, 1991 - 1995

HOSPITAL APPOINTMENTS

  • Radiation Oncologist-in-chief, Barnes-Jewish Hospital, St. Louis, 2008 - 2009
  • Consulting, Barnes, Jewish St. Peters Hospital, St. Peters, Missouri, 2006 - present
  • Consulting, John Cochran VA Medical Center, St. Louis, 2004 - 2008
  • Active, Barnes West County Hospital, Chesterfield, Missouri, 2000 - present
  • Clinical Chief of Radiation Oncology at St. Louis Children’s Hospital, St. Louis, 1994
  • Active, Barnes-Jewish Hospitals of St. Louis, 1991 - present
  • Consulting Staff, St. Louis Children’s Hospital, St. Louis, 1991 - present

SERVICE TO ASTRO

  • Member, Finance Committee Investment Advisor Task Force, 2021
  • Member, Joint VA-ASTRO Prostate Cancer Blue Ribbon Panel, 2021
  • Practical Radiation Oncology Journal Editor Selection Task Force, 2018 - 2019
  • Joint AUA/ASTRO/ASCO Bladder Cancer Guideline Panel, 2016 - 2017
  • Member, ASTRO Board of Directors, 2013 - 2017
  • Secretary/ Treasurer and Chair of ASTRO Finance Committee, 2013 - 2017
  • Executive Editor, Practical Radiation Oncology, 2013 - present
  • Co-Chair, Best Practices Subcommittee, 2011 - 2013
  • Clinical Affairs and Quality Committee, 2011 - 2013
  • Senior Editor, Practical Radiation Oncology, 2011 - 2013
  • Red Journal Editor Selection Task Force, 2010 - 2011
  • Prostate and Genitourinary Cancer Resource Panel, 2009 - present
  • ASTRO Nominating Committee, 2009 - 2011
  • Joint ASTRO/AUA Adjuvant Prostate Cancer Guideline Panel, 2009 - present
  • Co-chair, Monitoring Subcommittee of the Emerging Technology Steering Committee, 2007 - 2011
  • Government Relations FDA Subcommittee, 2005 - 2010
  • Government Relations CMS Subcommittee, 2005 - 2006
  • Health Policy and Economics Practice Management Subcommittee, 2005 - 2006
  • Emerging Technology Committee of the Health Policy Council, 2004 ‑ 2010
  • Finance/Audit Committee, 2004 - 2010
  • IT Development and Resources Committee, 2002 - 2004

SERVICE TO OTHER ONCOLOGY OR RADIOLOGY ORGANIZATIONS

  • Radiation Oncology Institute
  • ROI Finance Committee, 2018 - present
  • Research Committee, 2011 - 2013
  • American College of Radiology
  • Committee on Practice Parameters – Radiation Oncology, 2016 - present
  • Government Relations Committee, 2003 - 2009
  • Panel on Radiation Oncology, Prostate Work Group (Committee on Appropriateness Criteria), 2003 - 2009
  • Joint Economic Committee, 2002 - 2009
  • ACR Appropriateness Criteria Expert Panel, 2001 - 2009
  • American Radium Society
  • Chair, Nominating Committee, 2020 - present
  • American Society of Clinical Oncology
  • Genitourinary Cancer Guidelines Advisory Group, 2020 - present
  • Co-Chair, Bone Health and Bone-Targeted Therapy for Prostate Cancer Guideline, 2020
  • Chair, Genitourinary Cancer Symposium, 2012
  • Children’s Oncology Group (Pediatric Oncology Group)
  • ASTR 0431 Study Committee, 2005 - 2015
  • Central Nervous System Tumor Disease Committee, 2001 - present
  • Principal Investigator, Average Risk Medulloblastoma ACNS0331, 2000 ‑ present
  • Soft Tissue Sarcoma Committee, 1998 - present
  • Co-Chair, High Grade Glioma Subcommittee, 1997 - 2003
  • Chair, Quality Assurance Subcommittee, 1995 - 2003
  • National Comprehensive Cancer Network
  • Practice Guidelines Panel, 2006 - present
  • Non-melanoma Skin Cancer Panel, 2006 - 2013
  • Bladder Cancer Panel, 2006 - present
  • NRG Oncology Group
  • Co-Chair, Radiation Oncology Committee, 2012 - present
  • Member, GU steering Committee, 2012 - present
  • Radiation Therapy Oncology Group
  • Member, RTOG Foundation Board, 2013 - present
  • RTOG Group Vice-chair, 2008 - 2012
  • Steering Committee, 2008 - 2012
  • Executive Committee, 2008 - 2012
  • Principal Investigator, Washington University School of Medicine, 2002 ‑ 2018
  • Principal Investigator, RTOG 0126, Prostate Cancer Dose Escalation Trial
  • Research Strategy Committee, 1998 - 2012
  • Chairman, Advanced Technology Integration Committee, 1997 - 2012
  • Genitourinary Cancer Committee, 1997 - 2012
  • Brain Tumor Committee, 1996 - 2009
  • 3-D Quality Assurance Review Committee, 1992 - 2000
  • Radiologic Society of North America
  • Radiation Oncology Subcommittee of Refresher Course Committee, 2004 - 2007
  • Radiation Oncology and Radiobiology Subcommittee of the Program Committee, 1998 - 2003
  • RSNA Education Committee, 1986 - 2003

BIOGRAPHICAL SKETCH

Jeff Michalski, MD, MBA, FASTRO, is the Carlos Perez Distinguished Professor and vice-chairman of the Department of Radiation Oncology at Washington University Medical School. He earned a BS in biochemistry from the University of Wisconsin in 1982 and an MD from the Medical College of Wisconsin in 1986. After starting residency in radiation oncology at Columbia Presbyterian Medical Center in New York, he completed his residency training and fellowship at the Mallinckrodt Institute of Radiology and the Washington University School of Medicine in 1991. He earned an MBA from the Washington University Olin School of Business in 2001.

Dr. Michalski served as Vice-chair of the RTOG, leading its Advanced Technology Integration Committee. He is Co-chair of the Radiation Oncology Committee of the NRG. He was Chair of the Radiation Oncology Quality Assurance Committee of the Pediatric and Children's Oncology Groups. He is Co-chair of the NCI Genitourinary Steering Committee and member of the bladder cancer panel of the NCCN. He is a member of the Siteman Cancer Center and is Medical Director of the center’s Clinical Trials Core and Siteman Cancer Network.

Dr. Michalski’s research interests include radiation dose escalation in prostate cancer; conformal therapy to reduce toxicity and neuro-cognitive effects in children; assessment of quality of life in survivors of adult and childhood malignancies. He is the principal investigator of the Advanced Technology QA Center (ATC). He was co-principal investigator for the Veterans Administration Radiation Oncology Practice Assessment program, reviewing quality of care at forty VA radiation oncology centers.